Edwards Lifesciences Corp — Director's Dealing 2012

Oct 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-10-04

Reporting Person: BOBO DONALD E JR (CVP, Heart Valve Therapy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-10-04	Common Stock	M	11530.0000	$27.7700	Acquired	32552.0000	Direct
2012-10-04	Common Stock	S	11530.0000	$110.1380	Disposed	21022.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-04	Employee Stock Option (Right to Acquire)	$27.7700	M	11530.0000	Disposed	2015-05-07	Common Stock (11530.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4466.0000	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 28, 2011.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F3: This transaction was executed in multiple trades at prices ranging from $110.00 to $110.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.